EN DE
Watch Zhong Ji Longevity Science Group Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Zhong Ji Longevity Science Group Ltd (0767) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Zhong Ji Longevity Science Group Ltd stock HK$0.45, price HK$0.48, that is 5.7% below the price, quality 45 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare HK · ISIN BMG989M11008

ZJ Zhong Ji Longevity Science Group Ltd logo Thin data Nov 10, 2026

Zhong Ji Longevity Science Group Ltd

0767 · HK

The stock is already about fairly priced, weak company and price moving sideways: meets none of the 3 rules.

Get notified free when this changes
Revenue last quarter +51% vs. a year ago. 
Fair value HK$0.4525 · Fairly valued 
Quality 45/100 
Price moving sideways (no uptrend) 
Mixed Growth (revenue 5y +15.2 %/yr in HKD) 
Mixed vs. peers (4/9) 
Loss-making · -7.1% net margin (TTM) 
Negative free cash flow 
Narrow moat 13/100
Thin data 
Estimate
Watch Zhong Ji Longevity Science Group Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$7.90 HK$0.1080 Fair Value HK$0.4525 Apr 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range HK$0.1080 – HK$7.90 · fair‑value band HK$0.3394 – HK$0.5656 · the HK$0.4800 price screens above the HK$0.4525 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Zhong Ji Longevity Science Group in your weekly email

Every Wednesday you see whether Zhong Ji Longevity Science Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Zhong Ji Longevity Science Group Limited, an investment holding company, engages in the money lending business in Hong Kong and Mainland China.

Show moreShow less

It operates through Longevity Science Business; Money Lending and Financial Advisory Business; Securities and Other Investments; and Property Investment segments.

The company is involved in the provision of diagnostic consultation, health and medical testing and checking, and distribution of healthcare cancer prevention and immunity healthcare supplements, as well as sales and distribution of longevity wine.

It also engages in the holding of equity investments; investment in short and long-term financial assets; provision of loan financing and management services; and provision of financial and investment consulting, as well as financial advisory and management services; and investment in properties.

In addition, the company offers health consulting services, and trades in medical products. Zhong Ji Longevity Science Group Limited was incorporated in 1994 and is based in Kowloon Bay, Hong Kong.

Stock analysis

Zhong Ji Longevity Science Group Ltd (0767) currently trades at HK$0.4800, while our estimate is HK$0.4525, so the stock looks roughly fairly valued today (gap 6.0%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: HK$0.3394 (bear) to HK$0.5656 (bull), the price of HK$0.4800 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 45/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Spin-off in 2013: revenue and profit before it include the divested business. Growth is measured afresh from 2013.

Zhong Ji Longevity Science Group Ltd reported revenue of HK$165M in FY2025 versus HK$63.0M in FY2021, a compound +27.3%/yr. Reported net income was −HK$16.8M in FY2025.

Key figures

Market cap HK$306M (≈ $39.0M) Micro · P/S ratio 1.99 · Net margin −10.1% · Return on equity −2.3% · Return on assets (EBIT) 2.7% (5-year average) · Operating margin −9.1% · Revenue (TTM) HK$150M · Revenue growth (YoY) +50.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 13 out of 100 (medium confidence).

What moves the price

The share trades about 23% below its 52-week high and 45% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −10% fair-value upside, at −6%, 0767 screens cheaper than that median.

Fair Value

Bear HK$0.3394 Fair Value HK$0.4525 Bull HK$0.5656
Price HK$0.4800 · Downside -5.7%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 45/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 6
How much profit the company makes from its sales and capital
Quality Growth 50
Are margins and returns getting better?
Cashflow 20
Do the profits arrive as real cash?
Financial strength 72
Debt, balance sheet and risk of trouble
Investment 98
Does it invest with discipline instead of growing at any price?
Low Volatility 49
How calm the share price moves, does not count
Price momentum 51
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 37
Distance to the 52-week high, does not count
New shares 54
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Spin-off in 2013: revenue and profit before it include the divested business. Growth is measured afresh from 2013.
Revenue growth 1 year
−2.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.2%
Start year 2020 (pandemic). Over 10 years: +4.9% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.4%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−17.1% (2020) → −13.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch 0767, get fair value alerts →

Compare Zhong Ji Longevity Science Group Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 150 stocks

Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 45 · Below median
Fair Value upside −5.7% · Above median
Profitability
Return on assets −3.4% · Below median
Net margin (12 months) −7.1% · Below median
Operating margin (12 months) −9.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 50.7% · Top 25%

Valuation Multiplesvs Diagnostics & Research median · lower = cheaper

P/B 0.77× · Cheapest 25%
P/S (12 months) 2.04× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)26 · sector 12
FUTURE (revenue growth)100 · sector 35
PAST (return on equity)0 · sector 8
HEALTH (low debt)0 · sector 95
DIVIDEND (yield)0 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Illumina, Inc ILMN $207.01 $236.40 +14% vs 0767
WuXi AppTec Co 603259 ¥146.30 ¥165.37 +13% vs 0767
IQVIA Holdings IQV $265.12 $299.58 +13% vs 0767
Thermo Fisher Scientific Inc TMO $700.22 $686.04 −2% vs 0767
Danaher Corporation DHR $233.02 $209.18 −10% vs 0767
IDEXX Laboratories, Inc IDXX $704.23 $496.48 −30% vs 0767
Lonza Group LONN CHF 666.00 CHF 259.80 −61% vs 0767
Mettler-Toledo International Inc MTD $1,739 $655.06 −62% vs 0767
Agilent Technologies, Inc A $173.96 $64.53 −63% vs 0767
Waters Corporation WAT $460.25 $91.26 −80% vs 0767

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Zhong Ji Longevity Science Group Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Zhong Ji Longevity Science Group Ltd Fair Value". https://www.fairvalue-calculator.com/stock/0767

Frequently asked questions

Is Zhong Ji Longevity Science Group Ltd (0767) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is HK$0.4525 versus a price of HK$0.4800, about 6% lower (fairly valued).
What is the fair value of 0767?
Our estimate for Zhong Ji Longevity Science Group Ltd is HK$0.4525 (as of Nov 10, 2026), built from audited fundamentals. The current price: HK$0.4800.
What is the quality score of 0767?
Zhong Ji Longevity Science Group Ltd has a Quality Score of 45/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Zhong Ji Longevity Science Group Ltd (0767)?
Our calculated price target is the estimate of HK$0.4525 (as of Nov 10, 2026). Cautious scenario HK$0.3394, optimistic scenario HK$0.5656. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Zhong Ji Longevity Science Group Ltd stock forecast for 2026?
Our estimate puts fair value at HK$0.4525, about 6% lower versus a price of HK$0.4800 (fairly valued). Cautious scenario HK$0.3394, optimistic scenario HK$0.5656. The calculation is refreshed regularly with new filings.
What is the revenue of Zhong Ji Longevity Science Group Ltd (0767)?
Zhong Ji Longevity Science Group Ltd reported trailing-twelve-month revenue of about HK$150M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Zhong Ji Longevity Science Group Ltd (0767)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Zhong Ji Longevity Science Group Ltd it is HK$0.4525 per share (as of Nov 10, 2026), against a price of HK$0.4800.
Is Zhong Ji Longevity Science Group Ltd stock overvalued or undervalued in 2026?
As of Nov 10, 2026, 0767 trades above its calculated fair value: price HK$0.4800, fair value HK$0.4525, a gap of about −6% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0767?
No. The price is what the market pays today (HK$0.4800); the fair value is what the company's own numbers justify (HK$0.4525). For Zhong Ji Longevity Science Group Ltd the two are HK$0.0275 per share apart. That gap is exactly why we show both numbers side by side.
How much is Zhong Ji Longevity Science Group Ltd worth?
The market values Zhong Ji Longevity Science Group Ltd at about HK$306M (market capitalisation, as of Nov 10, 2026). Per share that is HK$0.4800; our models calculate a fair value of HK$0.4525 per share.
What do the bullish and bearish scenarios say about 0767?
Our models span a range for Zhong Ji Longevity Science Group Ltd: cautious scenario HK$0.3394, base HK$0.4525, optimistic HK$0.5656 per share (as of Nov 10, 2026, price HK$0.4800). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Zhong Ji Longevity Science Group Ltd (0767)?
Balance-sheet figures for Zhong Ji Longevity Science Group Ltd (as of Nov 10, 2026): return on equity −2.3%. They feed the Quality Score of 45/100, which measures business quality independently of the share price.
How far is 0767 from its 52-week high?
Zhong Ji Longevity Science Group Ltd trades at HK$0.4800, about 23% below its 52-week high of HK$0.6200 and 45% above the low of HK$0.3300 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.4525 is for.
Which stocks are comparable to Zhong Ji Longevity Science Group Ltd?
From the same area (Healthcare) we also value Thermo Fisher Scientific Inc, Danaher Corporation, WuXi AppTec Co, IDEXX Laboratories, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Zhong Ji Longevity Science Group Ltd stock attractive at the current price?
The data as of Nov 10, 2026: price HK$0.4800, calculated fair value HK$0.4525 (−6%), Quality Score 45/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 13.9% above its aggregate fair value. Zhong Ji Longevity Science Group Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Zhong Ji Longevity Science Group Ltd (0767)?
The closing price on Nov 13, 2026 was HK$0.4800. Our estimate is HK$0.4525, about 6% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Zhong Ji Longevity Science Group Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Zhong Ji Longevity Science Group Ltd

How large is the market capitalisation of Zhong Ji Longevity Science Group Ltd (0767)?
The market capitalisation of Zhong Ji Longevity Science Group Ltd is HK$306M (≈ $39.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Zhong Ji Longevity Science Group Ltd (0767)?
The price-to-sales ratio of Zhong Ji Longevity Science Group Ltd is 1.99 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Zhong Ji Longevity Science Group Ltd (0767)?
The net margin of Zhong Ji Longevity Science Group Ltd is −10.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Zhong Ji Longevity Science Group Ltd (0767)?
The return on equity (ROE) of Zhong Ji Longevity Science Group Ltd is −2.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Zhong Ji Longevity Science Group Ltd (0767)?
On an EBIT basis the return on assets of Zhong Ji Longevity Science Group Ltd is 2.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Zhong Ji Longevity Science Group Ltd (0767)?
The operating margin of Zhong Ji Longevity Science Group Ltd is −9.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Zhong Ji Longevity Science Group Ltd (0767)?
Revenue at Zhong Ji Longevity Science Group Ltd is growing +50.7% versus a year earlier (3y avg +22.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Zhong Ji Longevity Science Group Ltd (0767)?
Earnings per share at Zhong Ji Longevity Science Group Ltd are growing −75.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Zhong Ji Longevity Science Group Ltd (0767) generate?
The free cash flow of Zhong Ji Longevity Science Group Ltd is −HK$23.1M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Zhong Ji Longevity Science Group Ltd (0767) hold?
Zhong Ji Longevity Science Group Ltd holds more cash than debt, HK$18.7M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Zhong Ji Longevity Science Group Ltd in the live analysis

One click puts Zhong Ji Longevity Science Group Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.